These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32183927)

  • 1. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
    Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
    Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
    Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
    Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.
    Quattrone D; Reininghaus U; Richards AL; Tripoli G; Ferraro L; Quattrone A; Marino P; Rodriguez V; Spinazzola E; Gayer-Anderson C; Jongsma HE; Jones PB; La Cascia C; La Barbera D; Tarricone I; Bonora E; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Arrojo M; Tortelli A; Velthorst E; Berendsen S; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Kirkbride JB; Sham PC; O'Donovan MC; Cardno AG; Vassos E; van Os J; Morgan C; Murray RM; Lewis CM; Di Forti M;
    Transl Psychiatry; 2021 Aug; 11(1):423. PubMed ID: 34376640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.
    Quattrone D; Di Forti M; Gayer-Anderson C; Ferraro L; Jongsma HE; Tripoli G; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Lasalvia A; Tortelli A; Llorca PM; de Haan L; Velthorst E; Bobes J; Bernardo M; Sanjuán J; Santos JL; Arrojo M; Del-Ben CM; Menezes PR; Selten JP; ; Jones PB; Kirkbride JB; Richards AL; O'Donovan MC; Sham PC; Vassos E; Rutten BP; van Os J; Morgan C; Lewis CM; Murray RM; Reininghaus U
    Psychol Med; 2019 Jun; 49(8):1378-1391. PubMed ID: 30282569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
    Trotta G; Rodriguez V; Quattrone D; Spinazzola E; Tripoli G; Gayer-Anderson C; Freeman TP; Jongsma HE; Sideli L; Aas M; Stilo SA; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Tortelli A; Schürhoff F; Szöke A; Pignon B; Selten JP; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Richards A; Rutten BP; Van Os J; Austin-Zimmerman I; Li Z; Morgan C; Sham PC; Vassos E; Wong C; Bentall R; Fisher HL; Murray RM; Alameda L; Di Forti M;
    Psychol Med; 2023 Nov; 53(15):7375-7384. PubMed ID: 38078747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco use in first-episode psychosis, a multinational EU-GEI study.
    Sánchez-Gutiérrez T; Rodríguez-Toscano E; Roldán L; Ferraro L; Parellada M; Calvo A; López G; Rapado-Castro M; La Barbera D; La Cascia C; Tripoli G; Di Forti M; Murray RM; Quattrone D; Morgan C; van Os J; García-Portilla P; Al-Halabí S; Bobes J; de Haan L; Bernardo M; Santos JL; Sanjuán J; Arrojo M; Ferchiou A; Szoke A; Rutten BP; Stilo S; D'Andrea G; Tarricone I; ; Díaz-Caneja CM; Arango C
    Psychol Med; 2023 Nov; 53(15):7265-7276. PubMed ID: 37185055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
    Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
    Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls.
    Sami M; Quattrone D; Ferraro L; Tripoli G; Cascia E; Gayer-Anderson C; Selten JP; Arango C; Bernardo M; Tarricone I; Tortelli A; Gatto G; Del Peschio S; Del-Ben CM; Rutten BP; Jones PB; van Os J; de Haan L; Morgan C; Lewis C; Bhattacharyya S; Freeman TP; Lynskey M; Murray RM; Forti MD
    Psychol Med; 2021 Sep; 51(12):2074-2082. PubMed ID: 32340643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.
    Spinazzola E; Quattrone D; Rodriguez V; Trotta G; Alameda L; Tripoli G; Gayer-Anderson C; Freeman TP; Johnson EC; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Galatolo M; Tortelli A; Tagliabue I; Turco M; Pompili M; Selten JP; de Haan L; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; O'Donovan M; Rutten BP; Van Os J; Morgan C; Sham PC; Austin-Zimmerman I; Li Z; Vassos E; ; Murray RM; Di Forti M
    Psychol Med; 2023 Nov; 53(15):7418-7427. PubMed ID: 37129249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.
    Ricci V; Ceci F; Di Carlo F; Lalli A; Ciavoni L; Mosca A; Sepede G; Salone A; Quattrone D; Fraticelli S; Maina G; Martinotti G
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109118. PubMed ID: 34688166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high-potency cannabis on corpus callosum microstructure.
    Rigucci S; Marques TR; Di Forti M; Taylor H; Dell'Acqua F; Mondelli V; Bonaccorso S; Simmons A; David AS; Girardi P; Pariante CM; Murray RM; Dazzan P
    Psychol Med; 2016 Mar; 46(4):841-54. PubMed ID: 26610039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.
    Ferraro L; La Cascia C; Quattrone D; Sideli L; Matranga D; Capuccio V; Tripoli G; Gayer-Anderson C; Morgan C; Sami MB; Sham P; de Haan L; Velthorst E; Jongsma HE; Kirkbride JB; Rutten BPF; Richards AL; Roldan L; Arango C; Bernardo M; Bobes J; Sanjuan J; Santos JL; Arrojo M; Tarricone I; Tortelli A; Szöke A; Del-Ben CM; Selten JP; Lynskey M; Jones PB; Van Os J; La Barbera D; ; Murray RM; Di Forti M
    Schizophr Bull; 2020 Apr; 46(3):517-529. PubMed ID: 31361020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
    Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
    Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
    González-Blanco L; García-Portilla MP; Gutiérrez M; Mezquida G; Cuesta MJ; Urbiola E; Amoretti S; Barcones F; González-Pinto A; Pina-Camacho L; Corripio I; Vieta E; Baeza I; Toll A; Sáiz PA; Bobes J; Bernardo M;
    Schizophr Res; 2021 Oct; 236():19-28. PubMed ID: 34365082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of gender and cannabis in early phase psychosis.
    Crocker CE; Tibbo PG
    Schizophr Res; 2018 Apr; 194():18-25. PubMed ID: 28506705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study.
    Pignon B; Peyre H; Ayrolles A; Kirkbride JB; Jamain S; Ferchiou A; Richard JR; Baudin G; Tosato S; Jongsma H; de Haan L; Tarricone I; Bernardo M; Velthorst E; Braca M; Arango C; Arrojo M; Bobes J; Del-Ben CM; Di Forti M; Gayer-Anderson C; Jones PB; La Cascia C; Lasalvia A; Menezes PR; Quattrone D; Sanjuán J; Selten JP; Tortelli A; Llorca PM; van Os J; Rutten BPF; Murray RM; Morgan C; Leboyer M; Szöke A; Schürhoff F
    Epidemiol Psychiatr Sci; 2022 Sep; 31():e68. PubMed ID: 36165168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.